DK0384267T3 - Terapeutisk system til retarderet og styret transdermal eller transmucosal indgivelse af aktive stoffer - Google Patents

Terapeutisk system til retarderet og styret transdermal eller transmucosal indgivelse af aktive stoffer

Info

Publication number
DK0384267T3
DK0384267T3 DK90102771.4T DK90102771T DK0384267T3 DK 0384267 T3 DK0384267 T3 DK 0384267T3 DK 90102771 T DK90102771 T DK 90102771T DK 0384267 T3 DK0384267 T3 DK 0384267T3
Authority
DK
Denmark
Prior art keywords
active substance
layer
reservoir
active substances
retarded
Prior art date
Application number
DK90102771.4T
Other languages
English (en)
Inventor
Walter Dr Dipl-Chem Mueller
Heinrich Kindel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0384267T3 publication Critical patent/DK0384267T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
DK90102771.4T 1989-02-18 1990-02-13 Terapeutisk system til retarderet og styret transdermal eller transmucosal indgivelse af aktive stoffer DK0384267T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3905051A DE3905051A1 (de) 1989-02-18 1989-02-18 Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)

Publications (1)

Publication Number Publication Date
DK0384267T3 true DK0384267T3 (da) 1993-10-04

Family

ID=6374443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90102771.4T DK0384267T3 (da) 1989-02-18 1990-02-13 Terapeutisk system til retarderet og styret transdermal eller transmucosal indgivelse af aktive stoffer

Country Status (8)

Country Link
US (1) US5215751A (da)
EP (1) EP0384267B1 (da)
JP (1) JP2538372B2 (da)
AT (1) ATE89756T1 (da)
CA (1) CA2010225C (da)
DE (2) DE3905051A1 (da)
DK (1) DK0384267T3 (da)
ES (1) ES2058627T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105073A0 (en) † 1992-03-17 1993-07-08 Becton Dickinson Co User activated iontophoretic device and method for using same
WO1994008572A1 (en) * 1992-10-15 1994-04-28 Alza Corporation Delayed onset transdermal delivery device
DE4301781C2 (de) * 1993-01-23 1995-07-20 Lohmann Therapie Syst Lts Nitroglycerinhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
WO1996022083A1 (en) * 1995-01-19 1996-07-25 Cygnus, Inc. POLYISOBUTYLENE ADHESIVES CONTAINING HIGH Tg TACKIFIER FOR TRANSDERMAL DEVICES
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19814087A1 (de) * 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
DE19814083C2 (de) * 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19943317C1 (de) * 1999-09-10 2001-03-15 Lohmann Therapie Syst Lts Kunststofffolien, insbesondere für die Verwendung in einem dermalen oder transdermalen therapeutischen System und Verfahren zu ihrer Herstellung
KR100373447B1 (ko) * 2000-07-04 2003-02-25 강진양 약용탄을 이용한 파프제
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
JP2003300873A (ja) * 2002-04-12 2003-10-21 Nitto Denko Corp 貼付剤およびその製造方法
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
JPS6425717A (en) * 1987-05-08 1989-01-27 Eastman Kodak Co Method and apparatus for preventing organic nitric acid ester resistance
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device

Also Published As

Publication number Publication date
JPH02258717A (ja) 1990-10-19
CA2010225A1 (en) 1990-08-18
US5215751A (en) 1993-06-01
DE3905051A1 (de) 1990-08-30
CA2010225C (en) 1998-04-28
EP0384267B1 (de) 1993-05-26
ATE89756T1 (de) 1993-06-15
EP0384267A3 (en) 1990-12-19
DE59001522D1 (de) 1993-07-01
DE3905051C2 (da) 1991-08-08
ES2058627T3 (es) 1994-11-01
JP2538372B2 (ja) 1996-09-25
EP0384267A2 (de) 1990-08-29

Similar Documents

Publication Publication Date Title
DK0384266T3 (da) Terapeutisk system til forsinket og styret transdermal eller transmucosal afgivelse af virksomme stoffer
DK0384267T3 (da) Terapeutisk system til retarderet og styret transdermal eller transmucosal indgivelse af aktive stoffer
KR950007808A (ko) 약물투여용 의료용구
MY105279A (en) Transdermal therapeutic system comprising tulobuterol as active substance.
ES2062093T3 (es) Emplasto de varias capas.
ATE48762T1 (de) System zur verabreichung von substanzen durch die haut.
NL970007I1 (nl) Transdermaal oestradiotoedieningssysteem.
AU622775B2 (en) A plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release, process for the production of the plaster and the use thereof
NO884530D0 (no) Plaster med aktive stoffer for styrt avgivelse av aktive stoffer til huden, anvendelse saavel som fremgangsmaate for styrt avgivelse av aktive stoffer til huden.
ATE12731T1 (de) Polymere diffusionsmatrix und verfahren zu deren herstellung.
DE3485306D1 (de) Pharmazeutische zusammensetzung mit verzoegerter abgabe und verfahren zu deren herstellung.
ES2063172T3 (es) Sistema terapeutico superficial con una sustancia activa antineoplasica, en especial 5-fluoruracilo.
NO20000376L (no) Transdermalt terapeutisk system for frigiving av virkestoff gjennom huden inn i en organisme og fremgangsmõte for põføring põ huden
DK0865274T3 (da) Overfladestabiliseret, farmaceutisk præparat til påføring af huden
JPS577412A (en) Plaster
GR3002566T3 (en) Dermal and transdermal therapeutic system having a discontinuous-pattern adhesive layer and method of manufacturing thereof